Published: Oct 24, 2023, 06:45 IST | Updated: Oct 24, 2023, 06:45 IST
In a shocking revelation, global banks, including UBS and HSBC, have come under scrutiny for their investments in three publicly traded Chinese drugmakers accused of using parts of endangered animals in their products.